The Mouse Phenotyping team delivers phenotypic characterisation of mutant mice, typically knockouts of protein coding genes. Phenotyping encompasses a standardised set of more than 600 clinical parameters, and covers key biomedical areas such as reproduction, development, infection and immunity, musculoskeletal system, metabolism and endocrinology.
The Mouse Pipelines team supports biomedical research through the humane and optimized use of genetically-modified mice.
The Transgenic Technologies group produces mutant mice by utilising modified ES cell and Crispr/Cas9. All lines produced are cryopreserved and available for use by the wider scientific community.